A quantitative analysis of multilineage-differentiating stress-enduring (Muse) cells in human adipose tissue and efficacy of melanocytes induction

J Dermatol Sci. 2017 Jun;86(3):198-205. doi: 10.1016/j.jdermsci.2017.03.001. Epub 2017 Mar 6.

Abstract

We have shown previously that multilineage-differentiating stress-enduring (Muse) cells in neonatal fibroblasts can differentiate into functional melanocytes. In this study, we quantitate Muse cells in adipose-mesenchymal stem cells (adipose-MSCs) of human subcutaneous tissue obtained from 11 subjects of various ages, and measured efficacy of melanocytes induction from Adipose-MSC-derived Muse cells (hASC-Muse cells). There was a statistically significant negative correlation between the age of donors and the numbers of adipose-MSCs recovered per g fat as well as the percentage of SSEA3+ cells in the adipose-MSC populations, but isolated hASC-Muse cells showed pluripotency and growth curves equally regardless the age of donors. Adipose-Muse cells sequentially expressed melanocyte-related genes including KIT, MITF, TYRP1 PMEL, DCT, melanocortin 1 receptor (MC1R), and TYR at a comparable level to melanocytes during 6-week culture. Parallel with MC1R expression, adipose-Muse cells increased melanin content by α-MSH stimulation. By quantitating the cell numbers recovered at each step, we found that 10g of adipose tissue could produce at least 2.5×106 melanocytes after 6 weeks of culture. These studies suggest that induction of melanocytes from adipose-Muse is a novel approach to obtain sufficient numbers of melanocytes for clinical application and in vitro study of melanocyte differentiation.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Aged, 80 and over
  • Cell Differentiation / drug effects*
  • Cell Lineage*
  • Cell Proliferation / drug effects
  • Cell Separation / methods
  • Cells, Cultured
  • Child
  • Child, Preschool
  • Humans
  • Ligands
  • Melanins / metabolism*
  • Melanocytes / drug effects*
  • Melanocytes / metabolism
  • Mesenchymal Stem Cells / drug effects*
  • Mesenchymal Stem Cells / metabolism
  • Middle Aged
  • Phenotype
  • Pluripotent Stem Cells / drug effects*
  • Pluripotent Stem Cells / metabolism
  • Receptor, Melanocortin, Type 1 / agonists
  • Receptor, Melanocortin, Type 1 / metabolism
  • Signal Transduction / drug effects
  • Subcutaneous Fat / cytology*
  • Time Factors
  • alpha-MSH / pharmacology*

Substances

  • Ligands
  • Melanins
  • Receptor, Melanocortin, Type 1
  • alpha-MSH